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Clinical, hematological and angiographic characteristics of the patients
according to pre-procedural platelet to lymphocyte ratio tertiles
Variable
Tertile 1
88.2 (84.6-91.8)
n¼96
Tertile 2
135.2 (132.0-
138.4)
n¼96
Tertile 3
231.7 (220.5-
242.8) p value
Age,years 57.6  13.3 60.2  13.7 64.5  13.2 0.002
Male sex, n (%) 78 (81.3) 70 (72.9) 65 (68.4) 0.120
Hypertension, n (%) 29 (30.2) 29 (30.2) 40 (42.1) 0.135
Diabetes mellitus, n (%) 13 (13.5) 25 (26) 24 (25.3) 0.062
Smoking, n (%) 51 (53.1) 55 (57.3) 35 (36.8) 0.012
Glucose, mg/dl 151  72 151  63 170  80 0.051
Creatinine, mg/dl 0.88  0.20 0.83  0.20 0.89  0.27 0.109
C-reactive protein*, mg/dl 0.65  0.38 0.67  0.43 0.78  0.54 0.573
Total cholesterol, mg/dl 175  42 175  36 168  40 0.339
High-density lipoprotein, mg/dl 37  9 34  8 35  11 0.828
Low-density lipoprotein, mg/dl 106  32 110  32 108  30 0.648
Triglyceride, mg/dl 152  111 150  89 133  78 0.388
Hemoglobin, g/dl 14.1  1.4 14.1  1.4 13.8  1.5 0.305
Red-cell distribution width, % 15.9  1.3 15.9  1.3 16.1  1.2 0.084
Platelet count, x 109/L 233  59 254  46 294  68 <0.001
Mean platelet volume, ﬂ 8.2  1.2 8.1  1.1 8.0  1.1 0.221
White blood cell count, x 109/L 12.42  3.11 12.17  2.82 12.15  2.97 0.788
Neutrophile count, x 109/L 8.67  2.78 9.42  2.82 10.04  2.97 0.004
Lymphocyte count, x 109/L 2.75  0.96 1.90  0.38 1.34  0.46 <0.001
Neutrophil to lymphocyte ratio 3.44  1.47 5.24  2.20 8.44  3.83 <0.001
Pre-procedural TIMI ﬂow grade
0, n(%)
58 (60.4) 51 (53.1) 60 (63.2) 0.486
Post-procedural TIMI ﬂow grade
3, n (%)
90 (93.8) 86 (89.6) 52 (54.7) <0.001
Post-procedural TIMI ﬂow grade
2, n (%)
6 (6.3) 10 (10.4) 43 (45.3) <0.001
Drug eluting stents, n (%) 39 (40.6) 42 (43.8) 46 (48.4) 0.551
Stent diameter, mm 3.02  0.39 3.01  0.42 2.96  0.36 0.462
Stent length, mm 22.5  5.4 22.5  6.7 24.0  7.3 0.361
Pre-dilatation, n (%) 79 (82.3) 78 (81.3) 80 (84.2) 0.861
Post-dilatation, n (%) 53 (55.2) 55 (57.3) 51 (53.7) 0.881
Non-anterior myocardial
infarction, n (%)
49 (51) 49 (51) 51 (53.7) 0.668
*C-reactive protein levels were available for 175 patients.
Table 1. indicated that there were no statistically signiﬁcant differences
between the study groups with regard to demographic characteristics and
baseline laboratory ﬁndings.
Group I (n¼40) Group II (n¼61) P value
Male (n,%) 21(52) 41(67) 0.10
Age (years) 639 6310 0.95
BMI (kg/m2) 273.0 273.5 0.85
Smoking (n, %) 10(25) 21(34) 0.21
DM (n,%) 18(45) 21(34) 0.19
HT (n,%) 24(60) 29(48) 0.15
Hemoglobin(mg/dl) 13.81.5 13.91.6 0.87
Creatinine (mg/dl) 0.980.24 1.10.31 0.10
Total cholesterol (mg/dl) 198 40 195 37 0.88
LDL cholesterol (mg/dl) 12030 12535 0.48
HDL cholesterol (mg/dl) 418 409 0.75
Triglyceride (mg/dl) 18771 16487 0.28
Hs-CRP(mg/L) 7.82.2 3.61.4 0.001
Table 2. White blood cell, neutrophil, lymphocyte, and monocyte counts of
groups.
Group I
(n¼40)
Group II
(n¼61) P values
Neutrophils,(x1000/ml) 6.5 1.9 5.2 1.4 0.001
Lymphocytes,(x1000/ml) 1.7 0.6 2.50.6 0.001
Neutrophil/lymphocyte ratio 4.1 1.7 2.1 0.9 0.001
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Transcatheter Closure of PDAs at the Seriously Ill premature Babies
Osman Bas¸pınar, Metin Kılınç, Ahmet _Irdem, Derya Aydın S¸ahin,
Zatıgül S¸afak Taviloglu, Ercan Sivaslı
Gaziantep University Medical Faculty, Pediatric Cardiology Department, Gaziantep
Aım: The aim of this stud was to evaluate our institutional experience of transcatheter
closure of PDA at the seriously ill premature babies. Currently available technology is
not designed for these age groups. Transcatheter occlusion of PDA at the preterm
babies challenges the interventionist.
Methods: Eleven seriously ill premature infants underwent PDA closure with
different devices, if they still had clinically important PDA, despite appropriate
medical treatment. Only venous approach was used in nine patients. The Amplatzer
duct occluder (ADO) type II, Cook detachable coil and ADO type II additional sizes
were used. Co-morbid problems listed like this: respiratory distress syndrome in 9
patients, necrotizing enterocolitis in 7, intracranial hemorrhage in 7, bronchopulmo-
nary dysplasia in 5, extreme prematüre in 4, intravascular coagulopahty in 3, and renal
failure in 2, and pulmonary hemorrhage in 2 patients. All the patients had entubated.
Results: Gestational age of patients was ranged between 26-31 weeks. Mean birth
weight was 1120  260 (900-1610) gr, procedural weight was 1870  510 (1190-
2820) gr. Mean age of the patient was 36 (14 – 90) day. Mean PDA dimension at the
angiography was 2.55 (1–3.5) mm. 4F sheath was used at the all procedures. All
implantations were technically successful. Echocardiography conﬁrmed no residual
shunts on the following day. During manipulation, cardiac perforation occurred in one
patient and the patient was lost. Another patient died six days after procedure because
of co-morbid problems. PDAs were completely occluded without signiﬁcant
obstruction of the pulmonary arteries or aorta. Additional sizes were used in 9 times;
the others were used once.
Conclusıons: At these special age groups, delicate catheter and guidewire manipu-
lation is needed. Especially, the lower proﬁle and symmetry of ADO additional sizes
give the opportunity to close PDAs in premature babies Transcatheter technique is
possible at the seriously ill preterm infants. And it is a safe alternative to surgical
ligation especially for the critically ill patients.C226 JACC VoPP-367
Increased Neutrophile to Lymphocyte Ratio is Related with Poor Coronary
Collateral Development in Patients with Stable Coronary Artery Disease
Alparslan Kurtul, Mikail Yarlıoglues¸, Muhammed Karadeniz, Gökhan Ergün,
Mustafa Duran, Adil Hakan Öcek, Sani Namık Murat
Ankara Egitim ve Aras¸tırma Hastanesi, Ankara
Objectıves: The strong relationship between increased neutrophile to lymphocyte
ratio (NRL) and cardiovascular disease has been shown in many studies. In this study,
we investigated whether serum NLR levels affect coronary collateral circulation in
patients with stable coronary artery disease
Methods: The study population consisted of 101 patients who underwent coronary
angiography with a suspicion of coronary artery disease. Blood samples were taken and
NLR levels were analyzed for all patients. Rentrop collateral classiﬁcation was per-
formed. Patients were divided into two groups on the basis of Rentrop scores: group I
consisted of 40 patients (31 male, 16 female) with grade 0-1 collateral development
regarded as poor collateral group and group II consisted of 61 patients (29 male, 14
female) with grade 2-3 collateral development regarded as good collateral group.
Results: Table 1 indicated that there were no statistically signiﬁcant differences
between the study groups with regard to demographic characteristics and baseline
laboratory ﬁndings. Table 2 concluded that Group 1 had signiﬁcantly higher NLR
levels compared with Group 2 (6.51.9 vs. 5.21.4 mg/dl, p¼0.001). Figure 1
showed that NLR levels were higher in patients with absence of coronary collateral
compared with patients with presence of coronary collateral (4.01.7 vs. 2.61.5,
p¼0.001).
Conclusıon: Serum NLR level on admission is associated with poor CCC develop-
ment and may be a useful biomarker for stratiﬁcation of risk in patients with stable
coronary artery disease.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
